Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease: Galway, Ireland Saturday, March 1, 2025, 09:00 Hrs ...

Shares of Medtronic PLC MDT rallied 1.41% to $92.02 Friday, on what proved to be an all-around great trading session for the ...

Brainomix announced today that it entered into a strategic partnership with the Medtronic Neurovascular business unit.

The strategic partnership aims to increase access to Brainomix's AI technology for stroke treatment in Western Europe.

Over 80% of those living outside of biopharma’s biggest hubs, like San Diego or Boston, have a tough time finding work, ...

The strong dollar has been a continuing nuisance for U.S. companies with global operations, which convert their earnings ...

Wealthspire Advisors LLC lessened its stake in shares of Medtronic plc (NYSE:MDT – Free Report) by 40.6% during the 4th ...

The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...

ViCentra announced today that it appointed Tom Arnold as its new CEO to accelerate growth with the Kaleido automated insulin ...

We recently published a list of Dividend Stock Portfolio For Income: Top 10 Stocks to Buy. In this article, we are going to ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...